Segment disclosures

Company overview

CATABASIS PHARMACEUTICALS INC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 2 retained observations 1 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Single Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=atxs:SingleReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-07-01 – 2025-09-30706000 Unit_Standard_USD_cvxt7bs0n0K4STkVasc66g20251112Open filing evidence
2025-01-01 – 2025-09-30706000 Unit_Standard_USD_cvxt7bs0n0K4STkVasc66g20251112Open filing evidence